Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3255 USD | -0.18% | -11.45% | -93.79% |
May. 21 | Lyra Therapeutics Reduces Workforce to Extend Cash Runway | MT |
May. 21 | Lyra Therapeutics, Inc. Announces Cost-Cutting Measures to Preserve Capital | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-93.79% | 19.88M | |
+67.53% | 62.86B | |
-0.77% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+13.30% | 26.46B | |
-22.79% | 18.9B | |
+4.70% | 12.67B | |
+24.10% | 12.27B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- LYRA Stock
- News Lyra Therapeutics, Inc.
- Lyra Therapeutics Says Phase 2 Trial for Chronic Rhinosinusitis Treatment Meets Primary Endpoint